I A Global Asset Management Inc. Incyte Corp Transaction History

I A Global Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$51.18 - $63.75 $199,909 - $249,007	3,906 Added 100.08%	7,809 $473,000
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $49,877 - $58,732	-882 Reduced 18.43%	3,903 $222,000
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $42,458 - $52,250	814 Added 20.5%	4,785 $300,000
Q3 2023 Nov 15, 2023	SELL	$57.77 - $65.93 $228,884 - $261,214	-3,962 Reduced 49.94%	3,971 $229,000
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $483,516 - $599,020	7,933 New	7,933 $494,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on I A Global Asset Management Inc. with notifications on news.